These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 30811284)

  • 21. Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series.
    Benesch M; Mynarek M; Witt H; Warmuth-Metz M; Pietsch T; Bison B; Pfister SM; Pajtler KW; Kool M; Schüller U; Pietschmann K; Juhnke BO; Tippelt S; Fleischhack G; Schmid I; Kramm CM; Vorwerk P; Beilken A; Classen CF; Hernáiz Driever P; Kropshofer G; Imschweiler T; Lemmer A; Kortmann RD; Rutkowski S; von Hoff K
    Oncologist; 2019 Sep; 24(9):e921-e929. PubMed ID: 30850560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RELA fusion-positive ependymoma accompanied by extensive desmoplasia: a case report.
    Fukushima T; Ueda T; Hirato J; Kataoka H
    Brain Tumor Pathol; 2020 Oct; 37(4):159-164. PubMed ID: 32754892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment and survival of supratentorial and posterior fossa ependymomas in adults.
    Nuño M; Yu JJ; Varshneya K; Alexander J; Mukherjee D; Black KL; Patil CG
    J Clin Neurosci; 2016 Jun; 28():24-30. PubMed ID: 26810473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emotional and behavioral functioning after conformal radiation therapy for pediatric ependymoma.
    Willard VW; Conklin HM; Boop FA; Wu S; Merchant TE
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):814-21. PubMed ID: 24462384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort-A BIOMECA Consortium Study.
    Ritzmann TA; Chapman RJ; Kilday JP; Thorp N; Modena P; Dineen RA; Macarthur D; Mallucci C; Jaspan T; Pajtler KW; Giagnacovo M; Jacques TS; Paine SML; Ellison DW; Bouffet E; Grundy RG
    Neuro Oncol; 2022 Jun; 24(6):936-948. PubMed ID: 35018471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.
    Grill J; Le Deley MC; Gambarelli D; Raquin MA; Couanet D; Pierre-Kahn A; Habrand JL; Doz F; Frappaz D; Gentet JC; Edan C; Chastagner P; Kalifa C;
    J Clin Oncol; 2001 Mar; 19(5):1288-96. PubMed ID: 11230470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RELA Fusion in Supratentorial Extraventricular Ependymomas: A Morphologic, Immunohistochemical, and Molecular Study of 43 Cases.
    Wang L; Liu L; Li H; Wang P; Hu Z; Wei Y; Zhang M; Wen W; Li Z; Liu L; Zhao L; Lu D; Teng L
    Am J Surg Pathol; 2019 Dec; 43(12):1674-1681. PubMed ID: 31393268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pencil beam scanning proton therapy for pediatric intracranial ependymoma.
    Ares C; Albertini F; Frei-Welte M; Bolsi A; Grotzer MA; Goitein G; Weber DC
    J Neurooncol; 2016 May; 128(1):137-145. PubMed ID: 26945580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP).
    Kilday JP; Mitra B; Domerg C; Ward J; Andreiuolo F; Osteso-Ibanez T; Mauguen A; Varlet P; Le Deley MC; Lowe J; Ellison DW; Gilbertson RJ; Coyle B; Grill J; Grundy RG
    Clin Cancer Res; 2012 Apr; 18(7):2001-11. PubMed ID: 22338015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial.
    Venkatramani R; Ji L; Lasky J; Haley K; Judkins A; Zhou S; Sposto R; Olshefski R; Garvin J; Tekautz T; Kennedy G; Rassekh SR; Moore T; Gardner S; Allen J; Shore R; Moertel C; Atlas M; Dhall G; Finlay J
    J Neurooncol; 2013 Jun; 113(2):285-91. PubMed ID: 23508296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of tumor grade on time to progression after irradiation for localized ependymoma in children.
    Merchant TE; Jenkins JJ; Burger PC; Sanford RA; Sherwood SH; Jones-Wallace D; Heideman RL; Thompson SJ; Helton KJ; Kun LE
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):52-7. PubMed ID: 12007941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
    Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
    Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.
    Tauziède-Espariat A; Siegfried A; Nicaise Y; Kergrohen T; Sievers P; Vasiljevic A; Roux A; Dezamis E; Benevello C; Machet MC; Michalak S; Puiseux C; Llamas-Gutierrez F; Leblond P; Bourdeaut F; Grill J; Dufour C; Guerrini-Rousseau L; Abbou S; Dangouloff-Ros V; Boddaert N; Saffroy R; Hasty L; Wahler E; Pagès M; Andreiuolo F; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
    Acta Neuropathol Commun; 2021 Aug; 9(1):135. PubMed ID: 34389065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors and treatment options for paediatric ependymomas.
    Vaidya K; Smee R; Williams JR
    J Clin Neurosci; 2012 Sep; 19(9):1228-35. PubMed ID: 22840355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term survival following gross total resection of pediatric supratentorial ependymomas without adjuvant therapy.
    Tanaka T; Kato N; Hasegawa Y; Nonaka Y; Abe T
    Pediatr Neurosurg; 2012; 48(6):379-84. PubMed ID: 23948802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.
    Ramaswamy V; Hielscher T; Mack SC; Lassaletta A; Lin T; Pajtler KW; Jones DT; Luu B; Cavalli FM; Aldape K; Remke M; Mynarek M; Rutkowski S; Gururangan S; McLendon RE; Lipp ES; Dunham C; Hukin J; Eisenstat DD; Fulton D; van Landeghem FK; Santi M; van Veelen ML; Van Meir EG; Osuka S; Fan X; Muraszko KM; Tirapelli DP; Oba-Shinjo SM; Marie SK; Carlotti CG; Lee JY; Rao AA; Giannini C; Faria CC; Nunes S; Mora J; Hamilton RL; Hauser P; Jabado N; Petrecca K; Jung S; Massimi L; Zollo M; Cinalli G; Bognár L; Klekner A; Hortobágyi T; Leary S; Ermoian RP; Olson JM; Leonard JR; Gardner C; Grajkowska WA; Chambless LB; Cain J; Eberhart CG; Ahsan S; Massimino M; Giangaspero F; Buttarelli FR; Packer RJ; Emery L; Yong WH; Soto H; Liau LM; Everson R; Grossbach A; Shalaby T; Grotzer M; Karajannis MA; Zagzag D; Wheeler H; von Hoff K; Alonso MM; Tuñon T; Schüller U; Zitterbart K; Sterba J; Chan JA; Guzman M; Elbabaa SK; Colman H; Dhall G; Fisher PG; Fouladi M; Gajjar A; Goldman S; Hwang E; Kool M; Ladha H; Vera-Bolanos E; Wani K; Lieberman F; Mikkelsen T; Omuro AM; Pollack IF; Prados M; Robins HI; Soffietti R; Wu J; Metellus P; Tabori U; Bartels U; Bouffet E; Hawkins CE; Rutka JT; Dirks P; Pfister SM; Merchant TE; Gilbert MR; Armstrong TS; Korshunov A; Ellison DW; Taylor MD
    J Clin Oncol; 2016 Jul; 34(21):2468-77. PubMed ID: 27269943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The local field in infratentorial ependymoma: does the entire posterior fossa need to be treated?
    Paulino AC
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):757-61. PubMed ID: 11172959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic ependymoma: a multi-institutional retrospective analysis of prognostic factors.
    Zacharoulis S; Ji L; Pollack IF; Duffner P; Geyer R; Grill J; Schild S; Jaing TH; Massimino M; Finlay J; Sposto R
    Pediatr Blood Cancer; 2008 Feb; 50(2):231-5. PubMed ID: 17610266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy.
    Witt DA; Donson AM; Amani V; Moreira DC; Sanford B; Hoffman LM; Handler MH; Levy JMM; Jones KL; Nellan A; Foreman NK; Griesinger AM
    Pediatr Blood Cancer; 2018 May; 65(5):e26960. PubMed ID: 29350470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative radiation therapy for grade II and III intracranial ependymoma.
    Mansur DB; Perry A; Rajaram V; Michalski JM; Park TS; Leonard JR; Luchtman-Jones L; Rich KM; Grigsby PW; Lockett MA; Wahab SH; Simpson JR
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):387-91. PubMed ID: 15667957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.